Skip to main content
Erschienen in: Strahlentherapie und Onkologie 5/2014

01.05.2014 | Original article

Protection of quality and innovation in radiation oncology: The prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study)

Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT

verfasst von: Prof. Dr. H. Vorwerk, K. Zink, R. Schiller, V. Budach, D. Böhmer, S. Kampfer, W. Popp, H. Sack, R. Engenhart-Cabillic

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

A number of national and international societies published recommendations regarding the required equipment and manpower assumed to be necessary to treat a number of patients with radiotherapy. None of these recommendations were based on actual time measurements needed for specific radiotherapy procedures. The German Society of Radiation Oncology (DEGRO) was interested in substantiating these recommendations by prospective evaluations of all important core procedures of radiotherapy in the most frequent cancers treated by radiotherapy. The results of the examinations of radiotherapy with intensity-modulated radiation therapy (IMRT) in patients with different tumor entities are presented in this manuscript.

Patients, material, and methods

Four radiation therapy centers [University Hospital of Marburg, University Hospital of Giessen, University Hospital of Berlin (Charité), Klinikum rechts der Isar der Technischen Universität München] participated in this prospective study. The workload of the different occupational groups and room occupancies for the core procedures of radiotherapy were prospectively documented during a 2-month period per center and subsequently statistically analyzed.

Results

The time needed per patient varied considerably between individual patients and between centers for all the evaluated procedures. The technical preparation (contouring of target volume and organs at risk, treatment planning, and approval of treatment plan) was the most time-consuming process taking 3 h 54 min on average. The time taken by the medical physicists for this procedure amounted to about 57 %. The training part of the preparation time was 87 % of the measured time for the senior physician and resident. The total workload for all involved personnel comprised 74.9 min of manpower for the first treatment, 39.7 min for a routine treatment with image guidance, and 22.8 min without image guidance. The mean room occupancy varied between 10.6 min (routine treatment without image guidance) and 23.7 min (first treatment with image guidance).

Conclusion

The prospective data presented here allow for an estimate of the required machine time and manpower needed for the core procedures of radiotherapy in an average radiation treatment with IMRT. However, one should be aware that a number of necessary and time-consuming activities were not evaluated in the present study.
Literatur
1.
Zurück zum Zitat Bentzen SM, Heeren G, Cottier B et al (2005) Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 75:355–365PubMedCrossRef Bentzen SM, Heeren G, Cottier B et al (2005) Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 75:355–365PubMedCrossRef
2.
Zurück zum Zitat Blank E, Willich N, Fietkau R et al (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial. Strahlenther Onkol 188:113–111PubMedCrossRef Blank E, Willich N, Fietkau R et al (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial. Strahlenther Onkol 188:113–111PubMedCrossRef
3.
Zurück zum Zitat Budach W, Bölke E, Fietkau R et al (2011) Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol 187:449–460PubMedCrossRef Budach W, Bölke E, Fietkau R et al (2011) Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol 187:449–460PubMedCrossRef
4.
Zurück zum Zitat Fietkau R, Budach W, Zamboglou N et al (2012) Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial. Strahlenther Onkol 188:5–11PubMedCrossRef Fietkau R, Budach W, Zamboglou N et al (2012) Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial. Strahlenther Onkol 188:5–11PubMedCrossRef
5.
Zurück zum Zitat Lang K, Sussman M, Friedman M et al (2009) Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 135:582–588PubMedCrossRef Lang K, Sussman M, Friedman M et al (2009) Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 135:582–588PubMedCrossRef
7.
Zurück zum Zitat Palacios Eito A, Espinosa Calvo M et al (2008) Radiation oncology: future needs and equipment. Current situation in Spain. Clin Transl Oncol 10:478–485PubMedCrossRef Palacios Eito A, Espinosa Calvo M et al (2008) Radiation oncology: future needs and equipment. Current situation in Spain. Clin Transl Oncol 10:478–485PubMedCrossRef
8.
Zurück zum Zitat Ploquin N, Dunscombe P (2009) A cost-outcome analysis of Image-Guided Patient Repositioning in the radiation treatment of cancer of the prostate. Radiother Oncol 93:25–31PubMedCrossRef Ploquin N, Dunscombe P (2009) A cost-outcome analysis of Image-Guided Patient Repositioning in the radiation treatment of cancer of the prostate. Radiother Oncol 93:25–31PubMedCrossRef
9.
Zurück zum Zitat Slotman BJ, Cottier B, Bentzen SM et al (2005) Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.Radiother Oncol 75:349–354PubMedCrossRef Slotman BJ, Cottier B, Bentzen SM et al (2005) Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.Radiother Oncol 75:349–354PubMedCrossRef
10.
Zurück zum Zitat Slotman BJ, Vos PH (2013) Planning of radiotherapy capacity and productivity. Radiother Oncol 106:266–270PubMedCrossRef Slotman BJ, Vos PH (2013) Planning of radiotherapy capacity and productivity. Radiother Oncol 106:266–270PubMedCrossRef
11.
Zurück zum Zitat Van de Werf E, Lievensy, Verstraete J et al (2009) Time and motion study of radiotherapy delivery: economic burden of increased quality assurance and IMRT. Radiother Oncol 93:137–140PubMedCrossRef Van de Werf E, Lievensy, Verstraete J et al (2009) Time and motion study of radiotherapy delivery: economic burden of increased quality assurance and IMRT. Radiother Oncol 93:137–140PubMedCrossRef
12.
Zurück zum Zitat Zabel-du Bois A, Milker-Zabels, Henzel M et al (2012) Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery: QUIRO-DEGRO Trial. Strahlenther Onkol 188:769–776PubMedCrossRef Zabel-du Bois A, Milker-Zabels, Henzel M et al (2012) Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery: QUIRO-DEGRO Trial. Strahlenther Onkol 188:769–776PubMedCrossRef
Metadaten
Titel
Protection of quality and innovation in radiation oncology: The prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study)
Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT
verfasst von
Prof. Dr. H. Vorwerk
K. Zink
R. Schiller
V. Budach
D. Böhmer
S. Kampfer
W. Popp
H. Sack
R. Engenhart-Cabillic
Publikationsdatum
01.05.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 5/2014
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0634-0

Weitere Artikel der Ausgabe 5/2014

Strahlentherapie und Onkologie 5/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.